JP2001204492A - Method for assaying proliferation and activity of microorganism, and method for testing sensitivity - Google Patents

Method for assaying proliferation and activity of microorganism, and method for testing sensitivity

Info

Publication number
JP2001204492A
JP2001204492A JP2000015751A JP2000015751A JP2001204492A JP 2001204492 A JP2001204492 A JP 2001204492A JP 2000015751 A JP2000015751 A JP 2000015751A JP 2000015751 A JP2000015751 A JP 2000015751A JP 2001204492 A JP2001204492 A JP 2001204492A
Authority
JP
Japan
Prior art keywords
tetrazolium
tetrazolium compound
activity
microorganism
microorganisms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000015751A
Other languages
Japanese (ja)
Other versions
JP2001204492A5 (en
Inventor
Shirou Yamashiyouji
志朗 山庄司
Tsuneo Kaneko
常雄 金子
Kazuya Harufuji
和哉 春藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NIKKEN SEIBUTSU IGAKU KENKYUSH
Nikken Bio Medical Laboratory Inc
Original Assignee
NIKKEN SEIBUTSU IGAKU KENKYUSH
Nikken Bio Medical Laboratory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NIKKEN SEIBUTSU IGAKU KENKYUSH, Nikken Bio Medical Laboratory Inc filed Critical NIKKEN SEIBUTSU IGAKU KENKYUSH
Priority to JP2000015751A priority Critical patent/JP2001204492A/en
Publication of JP2001204492A publication Critical patent/JP2001204492A/en
Publication of JP2001204492A5 publication Critical patent/JP2001204492A5/ja
Pending legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a method for rapidly and readily assaying the proliferation and activity of microorganisms without breaking the microorganisms, and further to provide a method for testing the sensitivity for readily determining antimicrobial activity of various kinds of antimicrobial agents to the microorganisms. SOLUTION: This method for assaying the proliferation and/or activity of the microorganisms comprises culturing the microorganisms in the coexistence of a tetrazolium compound and an electron carrier to the tetrazolium compound, and determining the formazan formed by the reduction of the tetrazolium compound by spectroscopy. The method for evaluating the sensitivity of the microorganisms to the various kinds of the antimicrobial agents comprises culturing the microorganisms in the coexistence of the antimicrobial agents, the tetrazolium compound and the electron carrier to the tetrazolium compound, and determining the formazan formed by the reduction of the tetrazolium compound by spectroscopy. The tetrazolium compound and the formazan which is a reduction product thereof are water-soluble.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、微生物の増殖や活
性を迅速かつ簡便に測定する方法及びこの方法を用いる
感受性試験方法に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for quickly and simply measuring the growth and activity of a microorganism and a method for testing susceptibility using the method.

【0002】[0002]

【従来の技術】微生物検査における感受性試験や微生物
の活性・増殖速度・生存率の測定は、寒天培地上での集
落形成の目視観察、あるいは液体培地に含まれる菌の量
を培地の濁度を測定することで行ってきた。しかし、こ
れらの方法を用いる微生物の感受性試験は18から24時間
の長い培養時間が必要なため、臨床現場への迅速な結果
報告が妨げられ治療(特に投与すべき抗菌剤の決定)に
支障をきたしている。このような現状下において、より
迅速かつ簡便な感受性試験法の開発が強く望まれる。
2. Description of the Related Art A susceptibility test in a microorganism test and a measurement of the activity, growth rate, and survival rate of a microorganism are performed by visually observing the formation of a colony on an agar medium or by measuring the amount of bacteria contained in a liquid medium by measuring the turbidity of the medium. I went by measuring. However, microbiological susceptibility testing using these methods requires long culture times of 18 to 24 hours, which hinders rapid reporting to the clinical setting and hinders treatment (especially determination of the antimicrobial agent to be administered). I'm coming. Under these circumstances, it is strongly desired to develop a quicker and simpler sensitivity test method.

【0003】[0003]

【発明が解決しようとする課題】より迅速な微生物の薬
剤感受性試験法として、動物細胞の増殖速度測定に用い
られている酵素的還元反応を利用したテトラゾリウム還
元法の応用が考えられる。しかし、動物細胞の増殖速度
測定に用いられているテトラゾリウムは、例えば、3-
(4,5-ジメチル-2-チアゾリル)-2,5-ジフェニル-2Hテト
ラゾリウム塩(MTT)等であり、これらのほとんどが疎水
性であり、細胞内に浸透した後、酵素反応で還元され細
胞内に不溶性のホルマザンとして沈着してしまう傾向が
ある。したがって、発色を計測するには、細胞を破壊
し、均一に分散させる処理が必要であり、その後吸光度
を測定することになる。動物細胞の場合は、細胞が比較
的容易に破壊されるため、不溶性のホルマザンの均一分
散処理は比較的容易である。しかるに、微生物は動物細
胞よりも細胞膜が強固であるため、細胞破壊に対する処
理が困難であり、テトラゾリウム還元法を用いて増殖や
活性を測定することはできなかった。
As a more rapid test method for drug sensitivity of microorganisms, a tetrazolium reduction method utilizing an enzymatic reduction reaction used for measuring the growth rate of animal cells can be considered. However, tetrazolium used for measuring the growth rate of animal cells, for example, 3-
(4,5-dimethyl-2-thiazolyl) -2,5-diphenyl-2H tetrazolium salt (MTT), etc., most of which are hydrophobic, penetrate into cells, In the form of insoluble formazan. Therefore, in order to measure color development, a process of destroying cells and uniformly dispersing them is necessary, and thereafter, the absorbance is measured. In the case of animal cells, since the cells are relatively easily destroyed, it is relatively easy to uniformly disperse insoluble formazan. However, since microorganisms have a stronger cell membrane than animal cells, it is difficult to treat them against cell destruction, and their growth and activity could not be measured using the tetrazolium reduction method.

【0004】そこで細胞破壊処理をすることなしに、微
生物の増殖や活性を簡便迅速に測定できる方法の開発が
求められている。本発明の目的は、微生物の増殖及び活
性に関する測定を、微生物を破壊することなしに、迅速
かつ簡便に行うことができる方法を提供することにあ
る。さらに、本発明は上記測定方法を用い、微生物に対
する各種抗菌剤の抗菌力を簡便に決定することができる
感受性試験方法を提供することにある。
[0004] Therefore, there is a demand for the development of a method capable of simply and quickly measuring the growth and activity of microorganisms without performing cell destruction treatment. An object of the present invention is to provide a method capable of quickly and simply measuring the growth and activity of a microorganism without destroying the microorganism. Another object of the present invention is to provide a susceptibility test method that can easily determine the antibacterial activity of various antibacterial agents against microorganisms using the above-described measurement method.

【0005】[0005]

【課題を解決するための手段】本発明は、微生物をテト
ラゾリウム化合物及び該テトラゾリウム化合物への電子
キャリアーの共存下で培養し、前記テトラゾリウム化合
物が還元されて生成したホルマザンを分光法により定量
することで、前記の微生物の増殖及び/又は活性を測定
する方法であって、前記テトラゾリウム化合物及びその
還元生成であるホルマザンが水溶性であることを特徴と
する方法に関する。さらに本発明は、微生物を抗菌剤、
テトラゾリウム化合物及び該テトラゾリウム化合物への
電子キャリアーの共存下で培養し、前記テトラゾリウム
化合物が還元されて生成したホルマザンを分光法により
定量することで、前記の微生物の増殖及び/又は活性を
測定し、前記微生物の前記抗菌剤に対する感受性を評価
する方法であって、前記テトラゾリウム化合物及びその
還元生成であるホルマザンが水溶性であることを特徴と
する方法に関する。
According to the present invention, a microorganism is cultured in the presence of a tetrazolium compound and an electron carrier to the tetrazolium compound, and the formazan produced by reduction of the tetrazolium compound is quantified by spectroscopy. And a method for measuring the growth and / or activity of the microorganism, wherein the tetrazolium compound and formazan, which is a reduction product thereof, are water-soluble. Further, the present invention provides an antimicrobial agent for a microorganism,
Cultured in the presence of a tetrazolium compound and an electron carrier to the tetrazolium compound, by quantifying formazan generated by reduction of the tetrazolium compound by spectroscopy, to measure the growth and / or activity of the microorganism, The present invention relates to a method for evaluating the sensitivity of a microorganism to the antibacterial agent, wherein the tetrazolium compound and formazan, which is a reduction product thereof, are water-soluble.

【0006】[0006]

【発明の実施の形態】本発明の微生物の増殖及び/又は
活性を測定する方法及び抗菌剤に対する感受性を評価す
る方法では、テトラゾリウム化合物が水溶性であり、か
つその還元生成であるホルマザンが水溶性である化合物
を用いる。水溶性テトラゾリウム化合物を還元すること
により生成された水溶性ホルマザンは培養液中に均一に
溶解しており、微生物を破壊することなく直接吸光度の
測定が可能になる。水溶性テトラゾリウム化合物は、例
えば、ジスルホネートテトラゾリウム塩であることがで
きる。さらに、ジスルホネートテトラゾリウム塩として
は、2-(4-ヨードフェニル)-3-(4-ニトロフェニル)-5-
(2,4-ジスルホフェニル)-2H-テトラゾリウム塩及び2-(4
-ヨードフェニル)-3-(2,4-ジニトロフェニル)-5-(2,4-
ジスルホフェニル)-2H-テトラゾリウム塩を挙げること
ができる。これらの化合物は公知の化合物であり、試薬
として市販されているか、公知の方法により合成するこ
とができる。
BEST MODE FOR CARRYING OUT THE INVENTION In the method for measuring the growth and / or activity of a microorganism and the method for evaluating susceptibility to an antibacterial agent according to the present invention, a tetrazolium compound is water-soluble and its reduced product, formazan, is water-soluble. Is used. The water-soluble formazan produced by reducing the water-soluble tetrazolium compound is uniformly dissolved in the culture solution, so that the absorbance can be directly measured without destroying the microorganism. The water-soluble tetrazolium compound can be, for example, a disulfonate tetrazolium salt. Further, as the disulfonate tetrazolium salt, 2- (4-iodophenyl) -3- (4-nitrophenyl) -5-
(2,4-disulfophenyl) -2H-tetrazolium salt and 2- (4
-Iodophenyl) -3- (2,4-dinitrophenyl) -5- (2,4-
Disulfophenyl) -2H-tetrazolium salt. These compounds are known compounds and are commercially available as reagents or can be synthesized by known methods.

【0007】本発明の方法では、微生物をテトラゾリウ
ム化合物及びこのテトラゾリウム化合物への電子キャリ
アーの共存下で培養し、前記テトラゾリウム化合物が直
接または電子キャリアーを介して還元されて生成したホ
ルマザンを分光法により定量する。本発明の微生物の増
殖及び/又は活性の測定方法においては、培養液中の微
生物濃度は、例えば、107個〜108個程度とし、培養
液中のテトラゾリウム化合物の濃度は10〜300μg/m
l程度とすることができる。また、培養液に含まれる栄
養成分等やインキュベーションの温度は、微生物の種類
(至適pH及び至適温度)により適宜選択することがで
きる。また、培養時間も、微生物の増殖や活性が測定で
きる範囲で適宜決定できる。
In the method of the present invention, a microorganism is cultured in the presence of a tetrazolium compound and an electron carrier on the tetrazolium compound, and formazan produced by reduction of the tetrazolium compound directly or via an electron carrier is quantified by spectroscopy. I do. In the method of the present invention for measuring the growth and / or activity of a microorganism, the concentration of the microorganism in the culture solution is, for example, about 10 7 to 10 8 , and the concentration of the tetrazolium compound in the culture solution is 10 to 300 μg / m 2.
It can be about l. Further, nutrient components and the like contained in the culture solution and the temperature of the incubation can be appropriately selected depending on the type of the microorganism (optimal pH and optimal temperature). Further, the culture time can be appropriately determined within a range where the growth and activity of the microorganism can be measured.

【0008】電子キャリアーは、細胞内外の往来が可能
であり、微生物細胞内の酸化還元系とテトラゾリウム化
合物との間で電子の移行を媒介し、ホルマザンの生成を
容易にし、分光法による測定の感度を挙げることができ
る。上記電子キャリアーとしては、例えば、1-メトキシ
-5-メチルフェナジニウム メチルスルフェート及びフェ
ナジニウム メチルスルフェートを挙げることができ
る。これらの物質は市販品として容易に入手できる。上
記電子キャリアーは、培養液中に例えば、1〜10μg/ml
程度の濃度で添加することが適当である。
[0008] The electron carrier is capable of moving inside and outside the cell, mediating the transfer of electrons between the redox system and the tetrazolium compound in the microbial cell, facilitating the formation of formazan, and the sensitivity of measurement by spectroscopy. Can be mentioned. Examples of the electron carrier include, for example, 1-methoxy
And -5-methylphenazinium methyl sulfate and phenazinium methyl sulfate. These substances are readily available as commercial products. The electron carrier is, for example, 1 to 10 μg / ml in a culture solution.
It is appropriate to add it at a concentration of the order.

【0009】分光法による測定は以下のように行うこと
ができる。微生物を含む培養液にテトラゾリウム化合物
及び電子キャリアーを添加して培養を開始し、適当な間
隔で培養液から適量をサンプリングする。サンプリング
液の発色強度を吸光度として測定する。テトラゾリウム
化合物として2-(4-ヨードフェニル)-3-(4-ニトロフェニ
ル)-5-(2,4-ジスルホフェニル)-2H-テトラゾリウム塩を
用いる場合、生成するホルマザンの発光を450nmにおけ
る吸光度を経時的に測定することで、微生物の増殖状況
や活性を測定できる。
The measurement by spectroscopy can be performed as follows. The culture is started by adding the tetrazolium compound and the electron carrier to the culture solution containing the microorganism, and an appropriate amount is sampled from the culture solution at appropriate intervals. The color intensity of the sampling liquid is measured as absorbance. When 2- (4-iodophenyl) -3- (4-nitrophenyl) -5- (2,4-disulfophenyl) -2H-tetrazolium salt is used as the tetrazolium compound, the emission of formazan produced is determined by the absorbance at 450 nm. By measuring over time, the growth status and activity of the microorganism can be measured.

【0010】本発明の方法で増殖及び/又は活性の測定
をすることができる微生物には特に制限はなく、例え
ば、腸内細菌、緑膿菌、インフルエンザ菌、ブドウ球
菌、溶血連鎖球菌、腸球菌、バシラス、バクテロイデ
ス、クロストリジウム等を挙げることができる。本発明
の測定方法では、10分から数時間程度の時間で、微生物
の増殖状況や活性を測定することができる。
[0010] The microorganisms whose growth and / or activity can be measured by the method of the present invention are not particularly limited, and include, for example, enterobacteria, Pseudomonas aeruginosa, H. influenzae, staphylococci, hemolytic streptococci, enterococci. , Bacillus, Bacteroides, Clostridium and the like. The measuring method of the present invention can measure the growth status and activity of a microorganism in about 10 minutes to several hours.

【0011】本発明の感受性試験方法は、上記培養液中
での微生物の培養を抗菌剤の存在下で行うことで実施さ
れる。使用される抗菌剤の種類には特に制限はない。ま
た、培養液中の抗菌剤濃度を変化させて試験することや
2種以上の抗菌剤を併用することで、種々の角度から薬
剤感受性試験を行うこともできる。本発明の方法は、微
生物の破壊操作を必要とせず、しかも上記のように短時
間で薬剤の微生物に対する影響を評価することができる
ので、この時間内に薬物感受性試験が完了する。従来の
病原菌の薬物感受性試験は、細菌の増殖の変化を目視で
判定しているため、試験結果が得られるまでに最低でも
10時間以上必要であった。しかし、本発明の測定方法で
は、10分から数時間程度の時間で、薬物感受性試験を完
了することができる。
[0011] The susceptibility test method of the present invention is carried out by culturing a microorganism in the above culture solution in the presence of an antibacterial agent. There is no particular limitation on the type of antibacterial agent used. In addition, a drug sensitivity test can be performed from various angles by testing by changing the concentration of the antibacterial agent in the culture solution or by using two or more antibacterial agents in combination. Since the method of the present invention does not require the operation of destroying microorganisms and can evaluate the effect of the drug on microorganisms in a short time as described above, the drug sensitivity test is completed within this time. Conventional drug susceptibility testing of pathogens is based on visual observation of changes in bacterial growth.
It took more than 10 hours. However, in the measurement method of the present invention, the drug sensitivity test can be completed in about 10 minutes to several hours.

【0012】以下、本発明を実施例によりさらに詳細に
説明する。 実施例1 (各種テトラゾリウムを大腸菌が還元することにより生
ずる吸光度の比較)大腸菌(Eschrichia coliATCC2592
2)をミューラヒントン培地で増菌培養後、同培地で菌
体の濁度を600nmの波長で0.1の吸光度が得られるように
調整した。この菌浮遊液2.5mlに各種テトラゾリウム溶
液を添加後37℃で培養し、90分後に経時的に最大波長の
吸光度を測定した。尚、表1中、WST-1は2-(4-ヨードフ
ェニル)-3-(4-ニトロフェニル)-5-(2,4-ジスルホフェニ
ル)-2H-テトラゾリウム塩であり、MTTは3-(4,5-ジメチ
ル-2-チアゾリル)-2,5-ジフェニル-2Hテトラゾリウム塩
である。また、前述の菌懸濁液にテトラゾリウム化合物
と酸化還元反応を媒介する電子キャリアーである1-メト
キシ-5-メチルフェナジニウム メチルスルフェート(1-m
ethoxy-5-methyphenazinium-methylsulfate(以下1-MPM
S))の混合液を添加し、同様の操作にて吸光度を計測し
た。このときのテトラゾリウムの濃度は2.5mMで、1-MPM
Sの濃度は0.2mMとした。表1中、(+)が1-MPMSを添加した
系であり、(-)が1-MPMSを添加しなかった系である。
Hereinafter, the present invention will be described in more detail with reference to examples. Example 1 (Comparison of absorbance generated by reduction of various tetrazolium by Escherichia coli) Escherichia coli (Eschrichia coli ATCC2592
2) was enriched and cultured in a Mueller Hinton medium, and the turbidity of the cells was adjusted in the same medium so that an absorbance of 0.1 was obtained at a wavelength of 600 nm. After adding various tetrazolium solutions to 2.5 ml of the bacterial suspension, the cells were cultured at 37 ° C., and after 90 minutes, the absorbance at the maximum wavelength was measured over time. In Table 1, WST-1 is 2- (4-iodophenyl) -3- (4-nitrophenyl) -5- (2,4-disulfophenyl) -2H-tetrazolium salt, and MTT is 3 -(4,5-dimethyl-2-thiazolyl) -2,5-diphenyl-2H tetrazolium salt. In addition, 1-methoxy-5-methylphenazinium methyl sulfate (1-m), which is an electron carrier that mediates a redox reaction with a tetrazolium compound in the aforementioned bacterial suspension,
ethoxy-5-methyphenazinium-methylsulfate (hereinafter 1-MPM
The mixed solution of S)) was added, and the absorbance was measured by the same operation. The concentration of tetrazolium at this time is 2.5 mM, 1-MPM
The concentration of S was 0.2 mM. In Table 1, (+) indicates a system to which 1-MPMS was added, and (-) indicates a system to which 1-MPMS was not added.

【0013】結果は、表1のとおりである。尚、培養開
始時の吸光度はすべて0.1程度であった。1-MPMSを添加
しなかった系の場合、吸光度の経時的増加は、MTTで最
大であり、水溶性テトラゾリウムであるWST-1もMTTは同
程度であった。それに対して、本発明の1-MPMSを添加し
た系の場合、水溶性テトラゾリウムであるWST-1を用い
た場合、吸光度の経時的増加が他のテトラゾリウムに比
べて、格段に大きく、水溶性テトラゾリウム化合物と電
子キャリアーとを併用することで大きな効果を発揮する
ことが分かる。以上のように、WST-1のような水溶性テ
トラゾリウムと電子キャリアーである1-MPMSと組み合わ
せることで数時間以内に微生物の増殖状況や活性を簡便
に測定でき、より短い時間での測定が可能となる。
The results are as shown in Table 1. The absorbances at the start of the culture were all about 0.1. In the case of the system to which 1-MPMS was not added, the increase in absorbance with time was the largest in MTT, and the water-soluble tetrazolium WST-1 had the same MTT. On the other hand, in the case of the system to which 1-MPMS of the present invention is added, when WST-1, which is a water-soluble tetrazolium, is used, the absorbance with time is significantly increased as compared with other tetrazolium, and the water-soluble tetrazolium It can be seen that a great effect is exhibited by using the compound and the electron carrier together. As described above, by combining water-soluble tetrazolium such as WST-1 and 1-MPMS as an electron carrier, the growth status and activity of microorganisms can be easily measured within a few hours, and measurement can be performed in a shorter time Becomes

【0014】[0014]

【表1】 [Table 1]

【0015】実施例2 (大腸菌の初発濁度とWST-1の還元反応速度の関係)大
腸菌(Eschrichia coliATCC25922)をミューラヒントン
培地で増菌培養後、同培地で菌体の濁度を600nmの波長
で0.005から0.1の吸光度が得られるように調整した。96
ウエルのマイクロプレートに菌浮遊液250μlを分注した
後、2.5mMのWST-1と0.2mMの1-MPMSの混合液を25μlを添
加し、37℃で30分から120分間培養した。培養時間を30
分、60分、90分及び120分とした場合のホルマザンの吸
光度(波長450nm)及び濁度(600nm)を測定し、その関係を
図1に示す。初発濁度が600nmで吸光度が0.1のとき、90
分培養後には450nmの吸光度は0.1から1にまで増加し、W
ST-1と1-MPMSを用いない従来の濁度測定では得られない
大きな吸光度がこれら薬剤の使用によって短時間で得ら
れることを意味している。
Example 2 (Relationship between initial turbidity of Escherichia coli and reduction reaction rate of WST-1) Escherichia coli (Eschrichia coli ATCC25922) was enriched and cultured in a Mueller Hinton medium. Was adjusted so as to obtain an absorbance of 0.005 to 0.1. 96
After 250 μl of the bacterial suspension was dispensed into the well microplate, 25 μl of a mixture of 2.5 mM WST-1 and 0.2 mM 1-MPMS was added, and the mixture was cultured at 37 ° C. for 30 to 120 minutes. Culture time 30
The absorbance (wavelength 450 nm) and turbidity (600 nm) of formazan were measured for minutes, 60 minutes, 90 minutes and 120 minutes, and the relationship is shown in FIG. When the initial turbidity is 600 nm and the absorbance is 0.1, 90
After the minute culture, the absorbance at 450 nm increases from 0.1 to 1 and W
It means that a large absorbance, which cannot be obtained by conventional turbidity measurement without using ST-1 and 1-MPMS, can be obtained in a short time by using these agents.

【0016】実施例3 (濁度法とWST-1還元法によるポリミキシンBによる大腸
菌増殖阻害の測定)大腸菌(Eschrichia coliATCC2592
2)をミューラヒントン培地で増菌培養後、同培地で菌
体の濁度を600nmの波長で0.1の吸光度が得られるように
調整した。96ウエルのマイクロプレートに菌浮遊液250
μlを分注した後、2.5μg/mlから1μg/ml に調整したポ
リミキシンBの溶液を25μl加え、実施例2と同じ組成のW
ST-1と1-MPMSの混合溶液25μlを添加し、経時的に波長6
00nmで濁度を計測し、結果を図2に示す。これとは別に
450nmの吸光度も計測し、結果を図3に示す。図2及び
3中、記号◇、○および△はそれぞれ1μg/ml、2.5μg/
ml、5μg/mlのポリミキシンBの濃度を示す。また、□は
ポリミキシンB無添加の場合である。図2及び3の結果
から、細胞膜の機能を阻害するポリミキシンBは、いず
れの計測方法においても2時間培養でその阻害作用を確
認できる。しかし、培養2時間後に得られる陰性対象と
ポリミキシンBを1μg/ml添加した系との間における、図
2に示す濁度の数値(差)に比べて、図3に示すWST-1還
元の吸光度の数値(差)が約10倍大きく、本発明によれ
ば、阻害作用の判定がはるかに容易であることが分か
る。
Example 3 (Measurement of Escherichia coli growth inhibition by polymyxin B by turbidity method and WST-1 reduction method) Escherichia coli (Eschrichia ATCC2592)
2) was enriched and cultured in a Mueller Hinton medium, and the turbidity of the cells was adjusted in the same medium so that an absorbance of 0.1 was obtained at a wavelength of 600 nm. Cell suspension 250 in a 96-well microplate
After dispensing μl, 25 μl of a solution of polymyxin B adjusted from 2.5 μg / ml to 1 μg / ml was added, and W having the same composition as in Example 2 was added.
Add 25 μl of a mixed solution of ST-1 and 1-MPMS, and add
Turbidity was measured at 00 nm and the results are shown in FIG. Aside from this
The absorbance at 450 nm was also measured and the results are shown in FIG. 2 and 3, the symbols ◇, △ and △ are 1 μg / ml and 2.5 μg / ml, respectively.
Shows the concentration of polymyxin B in ml and 5 μg / ml. □ indicates the case where polymyxin B was not added. 2 and 3, the inhibitory effect of polymyxin B, which inhibits the function of the cell membrane, can be confirmed by culturing for 2 hours in any of the measurement methods. However, the figure between the negative control obtained after 2 hours of culture and the system to which 1 μg / ml of polymyxin B was added was shown.
Compared to the turbidity value (difference) shown in FIG. 2, the value (difference) of the absorbance of WST-1 reduction shown in FIG. 3 is about 10 times larger, and according to the present invention, it is much easier to determine the inhibitory effect. You can see that there is.

【0017】実施例4 (WST-1還元法を用いた各種抗菌剤による大腸菌の増殖
阻害測定)大腸菌(Eschrichia coliATCC25922)をミュ
ーラヒントン培地で増菌培養後、同培地で菌体の濁度を
600nmの波長で0.1の吸光度が得られるように調整した。
96ウエルのマイクロプレートに菌浮遊液250μlを分注し
た後、各種の抗菌剤溶液(25μl)を加え培養した。一
定時間後に実施例2と同じ組成のWST-1と1-MPMSの混合溶
液25μlを添加混合し、30分培養後に450nmの吸光度を測
定した。図4と5に示すように、DNA合成阻害剤(ノルフロキ
サシン)(図4)、代謝拮抗剤(トリメトフ゜リム)(図4)やたんぱく
質合成阻害剤(ケ゛ンタマイシン硫酸、クラリスロマイシン、クロラムフェニコ-
ル)(図5)は、WST-1より生成されたホルマザンの吸光度
は無添加のものと比べ低く菌の増殖を阻害しうる事が分
かった。よって、本測定方法は各種抗菌剤の抗菌力を評
価する感受性試験に用いることができる。なお、本実験
に使用した抗生剤の濃度は、次のとおりである。ノフロ
キサシン 0.12μg/ml、トリメトプリム 2μg/ml、ゲン
タマイシン硫酸1μg/ml、クラリスロマイシン 1μg/m
l、クロラムフェニコール 8μg/ml
Example 4 (Measurement of Escherichia coli Growth Inhibition by Various Antibacterial Agents Using WST-1 Reduction Method)
It was adjusted to obtain an absorbance of 0.1 at a wavelength of 600 nm.
After 250 μl of the bacterial suspension was dispensed into a 96-well microplate, various antibacterial agent solutions (25 μl) were added and cultured. After a certain period of time, 25 μl of a mixed solution of WST-1 and 1-MPMS having the same composition as in Example 2 was added and mixed, and after culturing for 30 minutes, the absorbance at 450 nm was measured. As shown in FIGS. 4 and 5, a DNA synthesis inhibitor (norfloxacin) (FIG. 4), an antimetabolite (trimethoprim) (FIG. 4) and a protein synthesis inhibitor (kentamicin sulfate, clarithromycin, chloramphenico-
(Fig. 5) shows that the absorbance of formazan generated from WST-1 is lower than that of the absence of formazan and can inhibit bacterial growth. Therefore, this measurement method can be used for a sensitivity test for evaluating the antibacterial activity of various antibacterial agents. The concentrations of the antibiotics used in this experiment are as follows. Nofloxacin 0.12 μg / ml, trimethoprim 2 μg / ml, gentamicin sulfate 1 μg / ml, clarithromycin 1 μg / m
l, chloramphenicol 8μg / ml

【図面の簡単な説明】[Brief description of the drawings]

【図1】実施例2で求めた大腸菌の初発濁度とWST-1の還
元反応速度。
FIG. 1 shows the initial turbidity of E. coli and the reduction reaction rate of WST-1 determined in Example 2.

【図2】実施例3で求めた濁度法によるポリミキシンBの
大腸菌増殖阻害。
FIG. 2 shows the inhibition of polymyxin B growth in Escherichia coli by the turbidity method determined in Example 3.

【図3】実施例3で求めた本発明(WST-1還元法)によるポ
リミキシンBの大腸菌増殖阻害。
FIG. 3 shows the inhibition of E. coli growth of polymyxin B by the present invention (WST-1 reduction method) determined in Example 3.

【図4】実施例4で求めた本発明(WST-1還元法)によるノル
フロキサシンとトリメトフ゜リムの大腸菌増殖阻害。
FIG. 4 shows the inhibition of E. coli growth of norfloxacin and trimethoprim by the present invention (WST-1 reduction method) determined in Example 4.

【図5】実施例4で求めた本発明(WST-1還元法)によるケ゛
ンタマイシン、クラリスロマイシン及びクロラムフェニコールの大腸菌増殖阻害。
FIG. 5 shows the inhibition of Escherichia coli growth of kentamicin, clarithromycin and chloramphenicol by the present invention (WST-1 reduction method) determined in Example 4.

フロントページの続き (72)発明者 金子 常雄 京都府久世郡久御山町大橋辺堤外縁23 株 式会社日研生物医学研究所内 (72)発明者 春藤 和哉 京都府久世郡久御山町大橋辺堤外縁23 株 式会社日研生物医学研究所内 Fターム(参考) 4B063 QA01 QA06 QA19 QQ05 QQ06 QQ61 QQ98 QR41 QR68 QR74 QR75 QS24 QX01 Continued on the front page (72) Inventor Tsuneo Kaneko Kyoto, Kuseyama-gun, Ohashibetsutsumi Outer Boundary 23, Nikken Biotechnology Research Institute (72) Inventor Kazuya Haruto, Kyoto, Kumiyama-cho, Ohmibetsue Outer Boundary 23, Kyoto F-term in Nikken Biomedical Research Institute (reference) 4B063 QA01 QA06 QA19 QQ05 QQ06 QQ61 QQ98 QR41 QR68 QR74 QR75 QS24 QX01

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】微生物をテトラゾリウム化合物及び該テト
ラゾリウム化合物への電子キャリアーの共存下で培養
し、前記テトラゾリウム化合物が還元されて生成したホ
ルマザンを分光法により定量することで、前記の微生物
の増殖及び/又は活性を測定する方法であって、前記テ
トラゾリウム化合物及びその還元生成であるホルマザン
が水溶性であることを特徴とする方法。
A microorganism is cultured in the presence of a tetrazolium compound and an electron carrier to the tetrazolium compound, and formazan generated by reduction of the tetrazolium compound is quantified by spectroscopy, whereby the growth and / or Or a method for measuring the activity, wherein the tetrazolium compound and formazan, which is a reduction product thereof, are water-soluble.
【請求項2】微生物を抗菌剤、テトラゾリウム化合物及
び該テトラゾリウム化合物への電子キャリアーの共存下
で培養し、前記テトラゾリウム化合物が還元されて生成
したホルマザンを分光法により定量することで、前記微
生物の前記抗菌剤に対する感受性を評価する方法であっ
て、前記テトラゾリウム化合物及びその還元生成である
ホルマザンが水溶性であることを特徴とする方法。
2. The microorganism is cultured in the presence of an antibacterial agent, a tetrazolium compound and an electron carrier to the tetrazolium compound, and formazan produced by reduction of the tetrazolium compound is quantified by spectroscopy. A method for evaluating sensitivity to an antibacterial agent, wherein the tetrazolium compound and formazan, which is a reduction product thereof, are water-soluble.
【請求項3】テトラゾリウム化合物が、ジスルホネート
テトラゾリウム塩である請求項1または2に記載の方
法。
3. The method according to claim 1, wherein the tetrazolium compound is a disulfonate tetrazolium salt.
【請求項4】ジスルホネートテトラゾリウム塩が2-(4-
ヨードフェニル)-3-(4-ニトロフェニル)-5-(2,4-ジスル
ホフェニル)-2H-テトラゾリウム塩または2-(4-ヨードフ
ェニル)-3-(2,4-ジニトロフェニル)-5-(2,4-ジスルホフ
ェニル)-2H-テトラゾリウム塩である請求項3に記載の
方法。 【請求事5】 電子キャリアーが1-メトキシ-5-メチルフ
ェナジニウム メチルスルフェートまたはフェナジニウ
ム メチルスルフェートである請求項1〜4のいずれか一
項に記載の方法。
4. The method according to claim 1, wherein the disulfonate tetrazolium salt is 2- (4-
(Iodophenyl) -3- (4-nitrophenyl) -5- (2,4-disulfophenyl) -2H-tetrazolium salt or 2- (4-iodophenyl) -3- (2,4-dinitrophenyl)- The method according to claim 3, which is a 5- (2,4-disulfophenyl) -2H-tetrazolium salt. 5. The method according to claim 1, wherein the electron carrier is 1-methoxy-5-methylphenazinium methyl sulfate or phenazinium methyl sulfate.
JP2000015751A 2000-01-25 2000-01-25 Method for assaying proliferation and activity of microorganism, and method for testing sensitivity Pending JP2001204492A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000015751A JP2001204492A (en) 2000-01-25 2000-01-25 Method for assaying proliferation and activity of microorganism, and method for testing sensitivity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000015751A JP2001204492A (en) 2000-01-25 2000-01-25 Method for assaying proliferation and activity of microorganism, and method for testing sensitivity

Publications (2)

Publication Number Publication Date
JP2001204492A true JP2001204492A (en) 2001-07-31
JP2001204492A5 JP2001204492A5 (en) 2006-12-21

Family

ID=18542996

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000015751A Pending JP2001204492A (en) 2000-01-25 2000-01-25 Method for assaying proliferation and activity of microorganism, and method for testing sensitivity

Country Status (1)

Country Link
JP (1) JP2001204492A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016073221A (en) * 2014-10-03 2016-05-12 株式会社シード Culture medium for acanthamoeba
JP2019534694A (en) * 2016-09-30 2019-12-05 マイクロバイオセンサー リミテッドMicrobiosensor Limited Methods and devices

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016073221A (en) * 2014-10-03 2016-05-12 株式会社シード Culture medium for acanthamoeba
JP2019534694A (en) * 2016-09-30 2019-12-05 マイクロバイオセンサー リミテッドMicrobiosensor Limited Methods and devices

Similar Documents

Publication Publication Date Title
US5292644A (en) Rapid process for detection coliform bacteria
JP4454846B2 (en) Detection of pathogenic microorganisms and their antimicrobial susceptibility
US20080166753A1 (en) Microbial Growth Assay
JPH09512438A (en) Microbiological medium
JP2001519167A5 (en)
EP2789692B1 (en) Method for measuring cells, and reagent for cell measurement
Merghni et al. Adhesive properties and extracellular enzymatic activity of Staphylococcus aureus strains isolated from oral cavity
JP2005519623A (en) Apparatus and method for detecting antibiotic inactivating enzyme
CN101233244A (en) Improved methods of detecting viability-associated molecules
EP1766046A1 (en) High ph test system for the determination of the presence of an antibiotic in a fluid
WO2000031292A1 (en) Method for counting living cells
JP2001204492A (en) Method for assaying proliferation and activity of microorganism, and method for testing sensitivity
WO1996014432A2 (en) Medium for detecting target microbes in a sample
JP2001161396A (en) Discrimination of microorganism in specimens
Ferencko et al. Esterase activity as a novel parameter of spore germination in Bacillus anthracis
US20040110247A1 (en) New molecular tools for the rapid assessment of the presence and viability of microorganisms and methods of use
JP3936660B2 (en) Rapid antibiotic susceptibility testing
KR102000202B1 (en) Test for determination of antibiotics in waste
JP2002500020A (en) A rapid method for assessing the inhibition and killing of anaerobic bacteria by toxic compounds.
JP2000500340A (en) Antibacterial antibacterial susceptibility assay
JP2007527723A (en) Quality assurance system for detecting microorganisms
JP4414176B2 (en) Coloring medium for Candida discrimination
Caschera et al. On Feasibility of Fluorescence-based Bacteria Presence Quantification: P. Aeruginosa.
RU2688117C1 (en) Method for evaluating pro- and antimicrobial properties of samples
RU2689359C1 (en) Method for determining the bactericidal properties of materials

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20061107

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061107

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091006

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100216